BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$615M |
| 2 |
State Street SPDR S&P Retail ETF
XRT
|
+$231M |
| 3 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$229M |
| 4 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$186M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$136M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.24B |
| 2 |
Microsoft
MSFT
|
+$620M |
| 3 |
Tesla
TSLA
|
+$594M |
| 4 |
Apple
AAPL
|
+$541M |
| 5 |
iShares MSCI ACWI ETF
ACWI
|
+$372M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.39% |
| 2 | Financials | 6.9% |
| 3 | Healthcare | 5.41% |
| 4 | Consumer Discretionary | 4.97% |
| 5 | Industrials | 3.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2301
Amphastar Pharmaceuticals
AMPH
$869M
| $910K | ﹤0.01% |
47,861
+25,212
| +111% | +$494K |
|
2302
Denali Therapeutics
DNLI
$3.87B
| $908K | ﹤0.01% |
17,999
+11,951
| +198% | +$674K |
|
2303
Werner Enterprises
WERN
$2.34B
| $908K | ﹤0.01% |
20,508
-471
| -2% | -$21.6K |
|
2304
Banc of California
BANC
$3.14B
| $908K | ﹤0.01% |
49,097
+28,692
| +141% | +$502K |
|
|
CLDR
2305
DELISTED
Cloudera, Inc.
CLDR
| $907K | ﹤0.01% |
56,769
+31,283
| +123% | +$496K |
|
|
HSII
2306
DELISTED
Heidrick & Struggles
HSII
| $906K | ﹤0.01% |
20,310
+13,282
| +189% | +$560K |
|
2307
Coherent
COHR
$65.6B
| $906K | ﹤0.01% |
15,270
-215,738
| -93% | -$14.1M |
|
2308
Harmonic Inc
HLIT
$1.49B
| $903K | ﹤0.01% |
103,173
+61,844
| +150% | +$554K |
|
2309
QuidelOrtho
QDEL
$1.01B
| $902K | ﹤0.01% |
6,389
-5,006
| -44% | -$673K |
|
|
PRSU
2310
Pursuit Attractions and Hospitality Inc
PRSU
$1.31B
| $901K | ﹤0.01% |
19,836
+12,679
| +177% | +$567K |
|
2311
National Vision
EYE
$1.49B
| $899K | ﹤0.01% |
15,842
+12,844
| +428% | +$710K |
|
|
QVCGA
2312
DELISTED
QVC Group Inc Series A
QVCGA
| $899K | ﹤0.01% |
1,765
-2,639
| -60% | -$1.48M |
|
2313
Arvinas
ARVN
$576M
| $899K | ﹤0.01% |
10,939
+6,242
| +133% | +$552K |
|
|
ARNA
2314
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $898K | ﹤0.01% |
15,076
+9,088
| +152% | +$537K |
|
2315
Beazer Homes USA
BZH
$874M
| $895K | ﹤0.01% |
51,913
+2,208
| +4% | +$39.5K |
|
2316
Empire State Realty Trust
ESRT
$829M
| $895K | ﹤0.01% |
89,203
-7,499
| -8% | -$80.9K |
|
|
NTUS
2317
DELISTED
Natus Medical Inc
NTUS
| $895K | ﹤0.01% |
35,672
+20,378
| +133% | +$519K |
|
2318
STAAR Surgical
STAA
$1.28B
| $895K | ﹤0.01% |
6,960
-2,424
| -26% | -$339K |
|
2319
World Acceptance Corp
WRLD
$898M
| $894K | ﹤0.01% |
4,714
+2,783
| +144% | +$514K |
|
2320
The RealReal
REAL
$1.34B
| $893K | ﹤0.01% |
67,784
+35,192
| +108% | +$521K |
|
2321
Domo
DOMO
$185M
| $889K | ﹤0.01% |
10,527
+6,289
| +148% | +$538K |
|
|
RC
2322
Ready Capital
RC
$299M
| $887K | ﹤0.01% |
61,480
+34,607
| +129% | +$524K |
|
2323
Mercury Insurance
MCY
$5.84B
| $884K | ﹤0.01% |
15,880
-1,206
| -7% | -$72K |
|
2324
Helen of Troy
HELE
$695M
| $881K | ﹤0.01% |
3,923
+645
| +20% | +$148K |
|
|
CNR
2325
Core Natural Resources Inc
CNR
$4.77B
| $881K | ﹤0.01% |
33,871
+19,540
| +136% | +$430K |
|
Similar funds
BNP Paribas Financial Markets's Q3 2021 Portfolio in Review
As of Q3 2021, BNP Paribas Financial Markets held 4,161 positions worth $70.6B, down 6.6% from $75.6B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
BNP Paribas Financial Markets withdrew a net $10.5B in Q3 2021, closing 150 positions and reducing 1,194 holdings. Its most notable exit was GE Aerospace, an estimated $147M position sold in full.
By sector, the portfolio is most concentrated in Technology at 10% of assets, down from 12% a quarter earlier, followed by Financials and Healthcare.
Against the trend, BNP Paribas Financial Markets opened a new position in iShares 10+ Year Investment Grade Corporate Bond ETF worth $5.86M.
- BNP Paribas Financial Markets's largest Q3 2021 buy was iShares 10+ Year Investment Grade Corporate Bond ETF: 84,600 shares worth $5.86M.
- BNP Paribas Financial Markets added most to iShares Russell 2000 ETF in Q3 2021, an estimated $615M increase.
- BNP Paribas Financial Markets's biggest Q3 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.24B.
- BNP Paribas Financial Markets fully exited GE Aerospace in Q3 2021, selling an estimated $147M.
- BNP Paribas Financial Markets's ten largest holdings make up 14% of its $70.6B portfolio in Q3 2021.
- BNP Paribas Financial Markets opened 102 new positions and closed 150 in Q3 2021.
- BNP Paribas Financial Markets's portfolio value fell 6.6% quarter-over-quarter to $70.6B.
Based on BNP Paribas Financial Markets's 13F filing for Q3 2021, filed 12 Nov 2021.